A Study to Assess the Pharmacodynamics of VK0214 in Male Subjects With AMN

Recruiting

Phase 1

A Study to Assess the Pharmacodynamics of VK0214 in Male Subjects With AMN

Sponsor:

Viking Therapeutics, Inc.

Code:

NCT04973657

Conditions

Adrenomyeloneuropathy Form (AMN) of X-linked Adrenoleukodystrophy (X-ALD)

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

VK0214

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information